References
1.         Wu D, Wu T, Liu Q, Yang Z. The SARS-CoV-2 outbreak: What we know. International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases. 2020;94:44-8. doi: 10.1016/j.ijid.2020.03.004.
2.         Hassan SA, Sheikh FN, Jamal S, Ezeh JK, Akhtar A. Coronavirus (COVID-19): A Review of Clinical Features, Diagnosis, and Treatment. Cureus. 2020;12(3):e7355. doi: 10.7759/cureus.7355.
3.         Abbas HM, Nassir KF, Al Khames Aga QA, Al-Gharawi AA, Rasheed JI, Al-Obaidy MW, et al. Presenting the characteristics, smoking versus diabetes, and outcome among patients hospitalized with COVID-19. Journal of medical virology. 2021;93(3):1556-67. doi: 10.1002/jmv.26487.
4.         Rabb H. Kidney diseases in the time of COVID-19: major challenges to patient care. The Journal of clinical investigation. 2020;130(6):2749-51. doi: 10.1172/jci138871.
5.         Palaiodimos L, Kokkinidis DG, Li W, Karamanis D, Ognibene J, Arora S, et al. Severe obesity, increasing age and male sex are independently associated with worse in-hospital outcomes, and higher in-hospital mortality, in a cohort of patients with COVID-19 in the Bronx, New York. Metabolism: clinical and experimental. 2020;108:154262. doi: 10.1016/j.metabol.2020.154262.
6.         Robbins-Juarez SY, Qian L, King KL, Stevens JS, Husain SA, Radhakrishnan J, et al. Outcomes for Patients With COVID-19 and Acute Kidney Injury: A Systematic Review and Meta-Analysis. Kidney international reports. 2020;5(8):1149-60. doi: 10.1016/j.ekir.2020.06.013.
7.         Davies SE, Portmann BC, O'Grady JG, Aldis PM, Chaggar K, Alexander GJ, et al. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology (Baltimore, Md). 1991;13(1):150-7.
8.         Pawlotsky JM. COVID-19 and the liver-related deaths to come. Nature reviews Gastroenterology & hepatology. 2020;17(9):523-5. doi: 10.1038/s41575-020-0328-2.
9.         Shinu P, Morsy MA, Deb PK, Nair AB, Goyal M, Shah J, et al. SARS CoV-2 Organotropism Associated Pathogenic Relationship of Gut-Brain Axis and Illness. Frontiers in molecular biosciences. 2020;7:606779. doi: 10.3389/fmolb.2020.606779.
10.      Wang X, Fang X, Cai Z, Wu X, Gao X, Min J, et al. Comorbid Chronic Diseases and Acute Organ Injuries Are Strongly Correlated with Disease Severity and Mortality among COVID-19 Patients: A Systemic Review and Meta-Analysis. Research (Washington, DC). 2020;2020:2402961. doi: 10.34133/2020/2402961.
11.      Lin S, Hong W, Basharat Z, Wang Q, Pan J, Zhou M. Blood Urea Nitrogen as a Predictor of Severe Acute Pancreatitis Based on the Revised Atlanta Criteria: Timing of Measurement and Cutoff Points. Canadian journal of gastroenterology & hepatology. 2017;2017:9592831. doi: 10.1155/2017/9592831.
12.      Ostermann M, Joannidis M. Acute kidney injury 2016: diagnosis and diagnostic workup. Critical care (London, England). 2016;20(1):299. doi: 10.1186/s13054-016-1478-z.
13.      Dufour DR, Lott JA, Nolte FS, Gretch DR, Koff RS, Seeff LB. Diagnosis and monitoring of hepatic injury. II. Recommendations for use of laboratory tests in screening, diagnosis, and monitoring. Clinical chemistry. 2000;46(12):2050-68. doi: 10.1093/clinchem/46.12.2050.
14.      Chronopoulos A, Rosner MH, Cruz DN, Ronco C. Acute kidney injury in elderly intensive care patients: a review. Intensive care medicine. 2010;36(9):1454-64. doi: 10.1007/s00134-010-1957-7.
15.      Coca SG. Acute kidney injury in elderly persons. American journal of kidney diseases : the official journal of the National Kidney Foundation. 2010;56(1):122-31. doi: 10.1053/j.ajkd.2009.12.034.
16.      Shao M, Li X, Liu F, Tian T, Luo J, Yang Y. Acute kidney injury is associated with severe infection and fatality in patients with COVID-19: A systematic review and meta-analysis of 40 studies and 24,527 patients. Pharmacological research. 2020;161:105107. doi: 10.1016/j.phrs.2020.105107.
17.      Kotta S, Aldawsari HM, Badr-Eldin SM, Alhakamy NA, Md S, Nair AB, et al. Combating the Pandemic COVID-19: Clinical Trials, Therapies and Perspectives. Frontiers in molecular biosciences. 2020;7:606393. doi: 10.3389/fmolb.2020.606393.
18.      Shah S, Diwan S, Soin A, Rajput K, Mahajan A, Manchikanti L, et al. Evidence-Based Risk Mitigation and Stratification During COVID-19 for Return to Interventional Pain Practice: American Society of Interventional Pain Physicians (ASIPP) Guidelines. Pain physician. 2020;23(4s):S161-s82.
19.      Samies NL, Pinninti S, James SH. Rhabdomyolysis and Acute Renal Failure in an Adolescent With Coronavirus Disease 2019. Journal of the Pediatric Infectious Diseases Society. 2020;9(4):507-9. doi: 10.1093/jpids/piaa083.
20.      Gerl K, Steppan D, Fuchs M, Wagner C, Willam C, Kurtz A, et al. Activation of Hypoxia Signaling in Stromal Progenitors Impairs Kidney Development. The American journal of pathology. 2017;187(7):1496-511. doi: 10.1016/j.ajpath.2017.03.014.
21.      Raza A, Estepa A, Chan V, Jafar MS. Acute Renal Failure in Critically Ill COVID-19 Patients With a Focus on the Role of Renal Replacement Therapy: A Review of What We Know So Far. Cureus. 2020;12(6):e8429. doi: 10.7759/cureus.8429.
22.      Gao YM, Xu G, Wang B, Liu BC. Cytokine storm syndrome in coronavirus disease 2019: A narrative review. Journal of internal medicine. 2021;289(2):147-61. doi: 10.1111/joim.13144.
23.      Kellum JA, Prowle JR. Paradigms of acute kidney injury in the intensive care setting. Nature reviews Nephrology. 2018;14(4):217-30. doi: 10.1038/nrneph.2017.184.
24.      Chen N, Zhou M, Dong X, Qu J, Gong F, Han Y, et al. Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study. Lancet (London, England). 2020;395(10223):507-13. doi: 10.1016/s0140-6736(20)30211-7.
25.      Shi H, Han X, Jiang N, Cao Y, Alwalid O, Gu J, et al. Radiological findings from 81 patients with COVID-19 pneumonia in Wuhan, China: a descriptive study. The Lancet Infectious diseases. 2020;20(4):425-34. doi: 10.1016/s1473-3099(20)30086-4.
26.      Yip TC, Lui GC, Wong VW, Chow VC, Ho TH, Li TC, et al. Liver injury is independently associated with adverse clinical outcomes in patients with COVID-19. Gut. 2021;70(4):733-42. doi: 10.1136/gutjnl-2020-321726.
27.      Bajaj JS, Garcia-Tsao G, Biggins SW, Kamath PS, Wong F, McGeorge S, et al. Comparison of mortality risk in patients with cirrhosis and COVID-19 compared with patients with cirrhosis alone and COVID-19 alone: multicentre matched cohort. Gut. 2021;70(3):531-6. doi: 10.1136/gutjnl-2020-322118.
28.      Medina-Caliz I, Robles-Diaz M, Garcia-Muñoz B, Stephens C, Ortega-Alonso A, Garcia-Cortes M, et al. Definition and risk factors for chronicity following acute idiosyncratic drug-induced liver injury. Journal of hepatology. 2016;65(3):532-42. doi: 10.1016/j.jhep.2016.05.003.
29.      Cai Q, Huang D, Yu H, Zhu Z, Xia Z, Su Y, et al. COVID-19: Abnormal liver function tests. Journal of hepatology. 2020;73(3):566-74. doi: 10.1016/j.jhep.2020.04.006.
30.      Li J, Fan JG. Characteristics and Mechanism of Liver Injury in 2019 Coronavirus Disease. Journal of clinical and translational hepatology. 2020;8(1):13-7. doi: 10.14218/jcth.2020.00019.
31.      Li Y, Xiao SY. Hepatic involvement in COVID-19 patients: Pathology, pathogenesis, and clinical implications. Journal of medical virology. 2020;92(9):1491-4. doi: 10.1002/jmv.25973.
32.      Liu C, Jiang ZC, Shao CX, Zhang HG, Yue HM, Chen ZH, et al. [Preliminary study of the relationship between novel coronavirus pneumonia and liver function damage: a multicenter study]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology. 2020;28(2):107-11. doi: 10.3760/cma.j.issn.1007-3418.2020.02.003.